Biotechnology · Healthcare
Board Member
2026-05-26–present
Board Member
Precision Biosciences Inc (DTIL)Equibles does not estimate personal net worth.
Get an email with a short summary when Precision Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get DTIL alertsGeno Germano is recorded as Board Member at Precision Biosciences Inc (DTIL) since May 26, 2026. Precision Biosciences Inc reported in an 8-K filed May 26, 2026 that Geno Germano was appointed Class I director, effective May 21, 2026. Precision Biosciences Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Precision Biosciences Inc includes Matthew Kane (CEO), Naresh Tanna (CFO), Alex Kelly (COO and Chief Accounting Officer) and 7 others.
“Based on the foregoing votes, Melinda Brown and Geno Germano were elected as Class I directors, and Item 2, Item 3, Item 4, Item 5, and Item 6 were approved.”
2026-05-26–present
Biotechnology · Healthcare
Board Member
2026-05-26–present